KATZ BARRETT (Chief Medical Officer) sold 29K shares of VIRIDIAN THERAPEUTICS, INC.\DE on the open market
Open‑market sale worth $1.08M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/18/2023ACC: 0000899243-23-002075
Officer· Chief Medical Officer
Since Jan 2021
-29K
Net shares
Net seller
$1.08M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
29K acquired · 58K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+4.15K
Price / share
$23.03
Trade value
$95.51K
% of position
New position
1/13/2023
0.00→4.15K
Common Stock
Direct
Shares
−4.15K
Price / share
$37.01
Trade value
$153.48K
% of position
New position
1/13/2023
4.15K→0.00
Common Stock
Direct
Shares
+24.85K
Price / share
$23.03
Trade value
$572.36K
% of position
New position
1/17/2023
0.00→24.85K
Common Stock
Direct
Shares
−24.85K
Price / share
$37.21
Trade value
$924.78K
% of position
New position
1/17/2023
24.85K→0.00
Total
Net shares
+0.00
Net value
-$410.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2023 | M · Option Exercise | +4.15K | $23.03 | $95.51K | New position | 0.00 | 4.15K |
| Common Stock Direct | 1/13/2023 | S · Sale | −4.15K | $37.01 | $153.48K | New position | 4.15K | 0.00 |
| Common Stock Direct | 1/17/2023 | M · Option Exercise | +24.85K | $23.03 | $572.36K | New position | 0.00 | 24.85K |
| Common Stock Direct | 1/17/2023 | S · Sale | −24.85K | $37.21 | $924.78K | New position | 24.85K | 0.00 |
| Total | +0.00 | -$410.39K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.15K shares
Shares
−4.15K
Strike price
23.03
Held after
291.85K
Exercisable
—
1/13/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
24.85K shares
Shares
−24.85K
Strike price
23.03
Held after
267K
Exercisable
—
1/17/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.15K shares | 1/13/2023 | M · Option Exercise | −4.15K | 23.03 | — | 291.85K |
| Stock Option (Right to Buy) Direct | Common Stock24.85K shares | 1/17/2023 | M · Option Exercise | −24.85K | 23.03 | — | 267K |